No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients.

Alicia Gutiérrez-ValenciaCoral GarcíaPompeyo VicianaYusnelkis Milanés-GuisadoTamara Fernandez-MagdalenoNuria EspinosaJuan PasquauLuis Fernando López-Cortés

Published in: PloS one (2018)

Boosted or unboosted ATV plus lamivudine is effective and safe, and the lower plasma Ctrough observed with ATV400 do not compromise the effectiveness of these simplification regimens in long-term virologically suppressed HIV-1-infected patients.

Keyphrases

hiv infected patients
antiretroviral therapy
randomized controlled trial
systematic review
hiv infected
combination therapy
replacement therapy